These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 22093311

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS.
    J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group.
    Gazzaniga GM, Angelini G, Pastorino G, Santoro E, Lucchini M, Dal Prà ML.
    Int Surg; 1993; 78(3):271-5. PubMed ID: 8276557
    [Abstract] [Full Text] [Related]

  • 5. Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.
    Amin AN, Lin J, Thompson S, Wiederkehr D.
    Ann Pharmacother; 2011 Sep; 45(9):1045-52. PubMed ID: 21862717
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
    Bauer KA, Eriksson BI, Lassen MR, Turpie AG, Steering Committee of the Pentasaccharide in Major Knee Surgery Study.
    N Engl J Med; 2001 Nov 01; 345(18):1305-10. PubMed ID: 11794149
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis.
    Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, Laporte S.
    Chest; 2005 Oct 01; 128(4):2203-10. PubMed ID: 16236875
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.
    Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Compan D, Saliba E, Weisslinger N, Huet Y.
    Drugs; 1996 Oct 01; 52 Suppl 7():47-54. PubMed ID: 9042560
    [Abstract] [Full Text] [Related]

  • 12. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E, Araújo GR, Lastoria S, Maffei FH, Karaoglan de Moura L, Michaelis W, Sandri JL, Dietrich-Neto F, CLETRAT Investigators.
    Thromb Res; 2004 Oct 01; 114(3):149-53. PubMed ID: 15342210
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
    Eriksson BI, Bauer KA, Lassen MR, Turpie AG, Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study.
    N Engl J Med; 2001 Nov 01; 345(18):1298-304. PubMed ID: 11794148
    [Abstract] [Full Text] [Related]

  • 15. Deep vein thrombosis and pulmonary embolism in the perioperative patient.
    Muntz JE.
    Am J Manag Care; 2000 Nov 01; 6(20 Suppl):S1045-52. PubMed ID: 11484304
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery.
    Scholten DJ, Hoedema RM, Scholten SE.
    Obes Surg; 2002 Feb 01; 12(1):19-24. PubMed ID: 11868291
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
    Turpie AG, Bauer KA, Davidson BL, Fisher WD, Gent M, Huo MH, Sinha U, Gretler DD, EXPERT Study Group.
    Thromb Haemost; 2009 Jan 01; 101(1):68-76. PubMed ID: 19132191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.